PubRank
Search
About
A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL
Clinical Trial ID NCT02046694
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT02046694
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Treatment of acute lymphoblastic leukemia.
N Engl J Med
2006
11.30
2
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
Blood
2012
2.82
3
Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
Clin Gastroenterol Hepatol
2007
2.77
4
The purine path to chemotherapy.
Science
1989
2.47
5
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.
N Engl J Med
1990
1.91
6
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
Aliment Pharmacol Ther
2005
1.79
7
Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts.
Inflamm Bowel Dis
2010
1.09
8
Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol.
Clin Pharmacol Ther
1983
1.00
9
Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease.
Aliment Pharmacol Ther
2008
0.96
10
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
Blood
1998
0.91
11
Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease.
Inflamm Bowel Dis
2008
0.77
12
Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism.
Pediatr Blood Cancer
2013
0.77
Next 100